ResMed | RMD - Gewinn Vor Steuern

Aktienkurs
32.28
Täglich Wechseln
-0.40 -1.22%
Monatlich
-5.64%
Jährlich
-5.64%
Q2 Prognose
31.51




Gewinn Vor Steuern Veränderung Datum
Ansell USD 33.35M 74.15M 2025-06
Avita Medical AUD -11.64M 12.13M 2025-12
Cochlear AUD 121.1M 155.6M 2025-06
CSL USD 2.61B 1.21B 2025-12
Fisher & Paykel Healthcare NZD 296.9M 90.5M 2025-06
Healius AUD -19.2M 3M 2025-06
Integral Diagnostics AUD 14.49M 47.37M 2024-06
Mayne Pharma AUD -14.7M 42.91M 2024-12
Nanosonics AUD 11.39M 487K 2025-06
Polynovo AUD 1.96M 146K 2025-12
Ramsay Health Care AUD 103.75M 54.35M 2025-06
Regis Healthcare AUD 42.8M 8.53M 2025-12
ResMed USD 496.15M 13.77M 2025-12
Sigma Healthcare AUD 8.15M 7.4M 2024-07
Sonic Healthcare AUD 402.01M 53.16M 2025-06
Telix Pharmaceuticals AUD 76.73M 66.04M 2025-06